Literature DB >> 8386513

Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.

M K Ghosh1, K Ghosh, J S Cohen.   

Abstract

Efforts have been made to reduce the disadvantages associated with the natural oligonucleotides (all-PO) for antisense application by introducing phosphorothioate (PS) linkages into the molecule. A series of such oligodeoxynucleotide copolymers (17-mers) complementary to the coding region of the rabbit beta-globin mRNA, and containing different proportions and arrangements of PO and PS bonds, were synthesized and tested for their protein-binding properties, nuclease stability in vitro, hybridizing ability with the complementary DNA (cDNA), ability to form RNase H-sensitive substrates and antisense activity in cell-free systems. The melting temperatures (Tm) of the co-polymers were reduced by up to 6 degrees C relative to the all-PO oligo, compared to 11 degrees C for the all-PS compound, indicating intermediate hybridizing abilities of the co-polymers. The protein-binding studies with human serum albumin exhibited a linear correlation with the percentage of PS linkage present in the molecule. Nuclease susceptibilities of the co-polymers were also improved, but the number and position of the PS linkages played a significant role in such improvement. Translation inhibition by these oligonucleotides was only found in wheat germ agglutinin (WGA) extract, but not in rabbit reticulocyte lysate (RRL) cell-free system, suggesting the involvement of RNase H in their antisense activities. Provided they have > or = 50% PS linkages, the co-polymers produced almost the same increased inhibition in the WGA system as that of the all-PS oligo. The translation arrest in WGA extract is in good agreement with the in vitro cleavage found for rabbit globin mRNA in the oligo:mRNA duplex by RNase H alone. It is concluded that a copolymer of PO and PS might be preferable to either all-PO or all-PS for antisense applications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386513

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  8 in total

Review 1.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

2.  Synthetic antisense oligodeoxynucleotides to transiently suppress different nucleus- and chloroplast-encoded proteins of higher plant chloroplasts.

Authors:  Emine Dinç; Szilvia Z Tóth; Gert Schansker; Ferhan Ayaydin; László Kovács; Dénes Dudits; Gyozo Garab; Sándor Bottka
Journal:  Plant Physiol       Date:  2011-10-06       Impact factor: 8.340

3.  Triple helix formation with purine-rich phosphorothioate-containing oligonucleotides covalently linked to an acridine derivative.

Authors:  J Lacoste; J C François; C Hélène
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

4.  Synthesis of phosphorothioate-methylphosphonate oligonucleotide co-polymers.

Authors:  L Zhou; A M Morocho; B C Chen; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

5.  On the rapid deprotection of synthetic oligonucleotides and analogs.

Authors:  N N Polushin; A M Morocho; B C Chen; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

6.  Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application.

Authors:  M K Ghosh; K Ghosh; O Dahl; J S Cohen
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

7.  Antisense pro-drugs: 5'-ester oligodeoxynucleotides.

Authors:  N N Polushin; J S Cohen
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

8.  Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity.

Authors:  Sumati Sundaram; Li Kim Lee; Charles M Roth
Journal:  Nucleic Acids Res       Date:  2007-06-18       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.